Aryl aniline beta-2 adrenergic receptor agonists

Details for Australian Patent Application No. 2002343662 (hide)

Owner Theravance, Inc.

Inventors Leadbetter, Michael, R.; Aggen, James; Jacobsen, John, R.; Nodwell, Matthew, B.; Church, Timothy, J.; Trapp, Sean, G.; Moran, Edmund, J.

Agent Davies Collison Cave

Pub. Number AU-B-2002343662

PCT Number PCT/US02/36237

PCT Pub. Number WO2003/042164

Priority 60/343,771 28.12.01 US; 60/338,194 13.11.01 US

Filing date 12 November 2002

Wipo publication date 26 May 2003

Acceptance publication date 26 June 2008

International Classifications

C07D 295/22 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/136 (2006.01) - having the amino group directly attached to the aromatic ring, e.g. benzeneamine

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

A61K 31/18 (2006.01) - Sulfonamides

A61K 31/245 (2006.01)

A61K 31/357 (2006.01) - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61K 31/366 (2006.01) - having six-membered rings, e.g. delta-lactones

A61K 31/4152 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/4402 (2006.01) - only substituted in position 2, e.g. pheniramine, bisacodyl

A61K 31/4453 (2006.01) - only substituted in position 1, e.g. propipocaine, diperodon

A61K 31/4704 (2006.01) - 2-Quinolinones, e.g. carbostyril

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61K 31/5377 (2006.01)

A61K 31/63 (2006.01) - Compounds containing para-N-benzene- sulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonohydrazide

A61K 31/635 (2006.01)

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 15/06 Drugs for genital or sexual disorders

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 60/343,771 28.12.01 US; 60/338,194 13.11.01 US

24 July 2003 Application Open to Public Inspection

  Published as AU-B-2002343662

26 June 2008 Application Accepted

  Published as AU-B-2002343662

23 October 2008 Standard Patent Sealed

9 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002343663-PRINTABLE SUBSTRATE HAVING CONTROLLABLE THICKNESS AND METHOD OF MAKING AND USING THE SAME

2002343661-MODIFIED PROSTAGLANDIN COMPOUNDS AND ANALOGS THEREOF, COMPOSITIONS CONTAINING THE SAME USEFUL FOR THE TEATMENT OF CANCER